Key result
T2DM is linked to ~27% greater major cardiovascular events risk after primary PCI for de novo lesions.
Why the study?
Do baseline and peak D-dimer values facilitate risk stratification in T2DM patients with late/very late stent thrombosis and de novo lesions undergoing primary PCI?
Cohort (n=3,941)
No
Do baseline and peak D-dimer values facilitate risk stratification in T2DM patients with late/very late stent thrombosis and de novo lesions undergoing primary PCI?
D-dimer levels and age may serve as useful markers for risk stratification in diabetic patients presenting with late/very late stent thrombosis or de novo lesions after primary PCI.
Answers are grounded in this paper and cite their sources.
T2DM was associated with higher MACE risk after primary PCI for de novo lesions; leaves open whether D-dimer aids stratification.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2021) conducted a cohort in Acute coronary syndrome with de novo lesions or late/very late stent thrombosis (n=3,941). Type 2 Diabetes Mellitus vs. Non-Diabetes Mellitus was evaluated on Major adverse cardiovascular events (MACEs), defined as death, myocardial infarction, revascularization, and ischemic stroke (HR 1.269, 95% CI 1.023-1.576, p=0.031). Type 2 diabetes mellitus increased the risk of major adverse cardiovascular events compared to non-diabetes mellitus in patients with de novo lesions undergoing primary percutaneous coronary intervention.
Synapse has enriched 10 related papers. Consider them for comparative context: